EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

REVIEW: COMPREHENSIVE STUDY OF DRUGS USED IN COVID 19 AND THEIR MODES OF ACTION

Atul Dilip Muthal*, Nilam Subhash Patangare, Divya Goraksha Thite, Rashmi Ramesh Pawar

ABSTRACT

The focus of the review is that Hydroxychloroquine is the drug primarily used to treat the covid virus. Acute Respiratory distress syndrome is a severe form of acute respiratory distress corona virus is a new and quickly spreading virus that causes corona virus illness. In 2019, Hydroxychloroquine and Chloroquine were both used against COVID-19. Favipiravir has a large margin of efficacy against various single-stranded RNA viruses, is well tolerated in humans, and has a strong barrier to resistance, depending on its mode of action and safety. Remdesivir is an analog of nucleotide prodrug that mainly inhibits SARS-CoV-2 RdRp. Its viral activities against SARS-CoV-2 have been shown both in vivo and vitro studies and are the most promisingly used till date due to its antiviral nature.

Keywords: Corona virus, Hydroxychloroquine, Favipiravir, Remdesvir, Mechanism.

[Full Text Article] [Download Certificate]